Our Leaders

Cornell Stamoran

Vice President, Corporate Development and Strategy, Investor Relations Officer

Cornell Stamoran was named Vice President, Corporate Development and Strategy, for Catalent Pharma Solutions in November 2007.

He has more than 17 years of experience in the pharmaceutical industry.

Since joining the Company in 1992, Mr. Stamoran has held many roles across a variety of disciplines, including financial and tax accounting, SEC reporting and financial planning; strategic business and technology planning; sales/business development; market intelligence; corporate development; marketing and branding; innovation; and public and investor relations.

Prior to Catalent, he worked at Arthur Andersen & Co.

In his current role, Mr. Stamoran leads Catalent’s market intelligence and strategic planning efforts, as well as supporting its global M&A activities. Additionally, he oversees corporate marketing and external communications, and serves as investor relations officer for the Company’s debt holders.

Mr. Stamoran holds a B.S. degree in accounting and management from the University of Michigan. He is also a certified public accountant (CPA), a certified management accountant (CMA), a certified information systems auditor (CISA), and a certified licensing professional (CLP). Besides being a member of the Association for Corporate Growth, the National Investor Relations Institute, the Society of Competitive Intelligence Professionals, the Public Relations Society of America, and the World Futures Society, Mr. Stamoran also has published articles in a variety of pharmaceutical trade publications. He has also served both as conference chairman and as a board member for several drug delivery industry conferences.